Evidence map›Paper›PMID 25541692›Full record

ArticlePloS one2014

Mechanical stress downregulates MHC class I expression on human cancer cell membrane.

Rosanna La Rocca, Rossana Tallerico, Almosawy Talib Hassan, Gobind Das, Tadepally Lakshmikanth, Lakshmikanth Tadepally, Marco Matteucci, Carlo Liberale, Maria Mesuraca, Domenica Scumaci and 10 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 5 countries.

Rosanna La RoccaDepartment of Experimental and Clinical Medicine, University of "Magna Graecia", Catanzaro, Italy; Italian Institute of Technology (IIT), Genova, Italy.
Rossana TallericoDepartment of Experimental and Clinical Medicine, University of "Magna Graecia", Catanzaro, Italy.
Almosawy Talib HassanDepartment of Experimental and Clinical Medicine, University of "Magna Graecia", Catanzaro, Italy; Department of Microbiology, College of Medicine, University of Thi-Qar, Nasseriah, Iraq.
Gobind DasDepartment of Experimental and Clinical Medicine, University of "Magna Graecia", Catanzaro, Italy; King Abdullah University of Science and Technology, Thuwal, Kingdom of Saudi Arabia.
Tadepally Lakshmikanth
Lakshmikanth TadepallyScience for Life Laboratory, Department of Medicine, Karolinska Institute, Stockholm, Sweden.
Marco MatteucciNanotech Department of Micro- and Nanotechnology, Technical University of Denmark, Kongens Lyngby, Denmark.
Carlo LiberaleDepartment of Experimental and Clinical Medicine, University of "Magna Graecia", Catanzaro, Italy; King Abdullah University of Science and Technology, Thuwal, Kingdom of Saudi Arabia.
Maria MesuracaDepartment of Experimental and Clinical Medicine, University of "Magna Graecia", Catanzaro, Italy.
Domenica ScumaciDepartment of Experimental and Clinical Medicine, University of "Magna Graecia", Catanzaro, Italy.
Francesco GentileDepartment of Experimental and Clinical Medicine, University of "Magna Graecia", Catanzaro, Italy.
Gheorghe CojocDepartment of Experimental and Clinical Medicine, University of "Magna Graecia", Catanzaro, Italy.
Gerardo PerozzielloDepartment of Experimental and Clinical Medicine, University of "Magna Graecia", Catanzaro, Italy.
Antonio AmmendoliaDepartment of Surgical and Medical Sciences, University of "Magna Graecia", Catanzaro, Italy.
Adriana GalloEndocrinology and Experimental Oncology Institute, CNR, Napoli, Italy.
Klas KärreDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.
Giovanni CudaDepartment of Experimental and Clinical Medicine, University of "Magna Graecia", Catanzaro, Italy.
Patrizio CandeloroDepartment of Experimental and Clinical Medicine, University of "Magna Graecia", Catanzaro, Italy.
Enzo Di FabrizioDepartment of Experimental and Clinical Medicine, University of "Magna Graecia", Catanzaro, Italy; King Abdullah University of Science and Technology, Thuwal, Kingdom of Saudi Arabia.
Ennio CarboneDepartment of Experimental and Clinical Medicine, University of "Magna Graecia", Catanzaro, Italy; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.
Magna Graecia University · ITKarolinska Institutet · SEKing Abdullah University of Science and Technology · SAInstitute for Experimental Endocrinology and Oncology · ITItalian Institute of Technology · ITTechnical University of Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In our body, cells are continuously exposed to physical forces that can regulate different cell functions such as cell proliferation, differentiation and death. In this work, we employed two different strategies to mechanically stress cancer cells. The cancer and healthy cell populations were treated either with mechanical stress delivered by a micropump (fabricated by deep X-ray nanolithography) or by ultrasound wave stimuli. A specific down-regulation of Major Histocompatibility Complex (MHC) class I molecules expression on cancer cell membrane compared to different kinds of healthy cells (fibroblasts, macrophages, dendritic and lymphocyte cells) was observed, stimulating the cells with forces in the range of nano-newton, and pressures between 1 and 10 bar (1 bar = 100.000 Pascal), depending on the devices used. Moreover, Raman spectroscopy analysis, after mechanical treatment, in the range between 700-1800 cm(-1), indicated a relative concentration variation of MHC class I. PCA analysis was also performed to distinguish control and stressed cells within different cell lines. These mechanical induced phenotypic changes increase the tumor immunogenicity, as revealed by the related increased susceptibility to Natural Killer (NK) cells cytotoxic recognition.

Indexed as

Cell MembraneCells, CulturedDown-RegulationHEK293 CellsHistocompatibility Antigens Class IHumansKiller Cells, NaturalNeoplasmsPhenotypeSpectrum Analysis, RamanStress, MechanicalTumor EscapeHistocompatibility Antigens Class I

Identifiers

PMID25541692
PMCPMC4277281
OpenAlexW2001041814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.